Apinya Boonpeng

Overview

Explore the profile of Apinya Boonpeng including associated specialties, affiliations and a list of published articles.

Snapshot

Articles 10

Citations 43

Followers 0

Related Specialties

Pharmacology

Critical Care

Hematology

Top 10 Co-Authors

Sutthiporn Pattharachayakul

Taniya Charoensareerat

Weerachai Chaijamorn

Nattachai Srisawat

Sutep Jaruratanasirikul

Maseetoh Samaeng

Monchana Nawakitrangsan

Thitima Wattanavijitkul

Rungsun Bhurayanontachai

Sirima Sitaruno

Published In

J Crit Care

J Clin Pharmacol

J Intensive Care

Osteoporos Sarcopenia

Antimicrob Agents Chemother

Affiliations

Soon will be listed here.

Recent Articles

The Effects of the Early and Late Phases of Septic Shock on the Population Pharmacokinetics of Vancomycin

Lexnoi T, Boonpeng A, Santimaleeworagun W, Chaisiri K, Dechsanga J, Vattanavanit V, et al.

J Clin Pharmacol . 2025 Feb; PMID: 39967294

Pathophysiologic changes in the early and late phases of septic shock affect the pharmacokinetic (PK) parameters, varying dose adjustments may be necessary. This study aimed to create the PK models...

Population Pharmacokinetic Simulations for Dose Optimization of Tenofovir Disoproxil Fumarate in HIV-Infected Patients with Moderate-to-Severe Renal Impairment

Boonpeng A, Singkham N, Wutthikul C, Rattanakul T, Weeket P, Saengpraphanan C, et al.

J Clin Pharmacol . 2024 Oct; PMID: 39415758

Tenofovir disoproxil fumarate (TDF) requires dosage adjustments from the standard 300 mg once daily to every 48-96 h for moderate-to-severe renal impairment to avoid excessive exposure. However, this extended interval...

Optimal Meropenem Dosing Regimens in Patients Undergoing Continuous Renal Replacement Therapy: Systematic Review and Monte Carlo Simulations

Charoensareerat T, Chaijamorn W, Kerdnimith P, Kosumwisaisakul N, Teeranaew P, Rungkitwattanakul D, et al.

Blood Purif . 2023 May; 52(6):503-515. PMID: 37231811

Introduction: The optimal meropenem dosing regimens in critically ill patients receiving continuous renal replacement therapy (CRRT) based on pharmacokinetic and pharmacodynamic (PD) concepts are not well established. This study aimed...

Population Pharmacokinetics/Pharmacodynamics and Clinical Outcomes of Meropenem in Critically Ill Patients

Boonpeng A, Jaruratanasirikul S, Jullangkoon M, Samaeng M, Wattanavijitkul T, Bhurayanontachai R, et al.

Antimicrob Agents Chemother . 2022 Oct; 66(11):e0084522. PMID: 36226944

Several pathophysiological changes can alter meropenem pharmacokinetics in critically ill patients, thereby increasing the risk of subtherapeutic concentrations and affecting therapeutic outcomes. This study aimed to characterize the population pharmacokinetic...

Population pharmacokinetics of oral levofloxacin in healthy volunteers and dosing optimization for multidrug-resistant tuberculosis therapy

Boonpeng A, Jaruratanasirikul S, Wattanavijitkul T, Nawakitrangsan M, Samaeng M

Biopharm Drug Dispos . 2021 Jun; 42(7):329-337. PMID: 34117648

Levofloxacin is considered a key component of a multidrug-resistant tuberculosis (MDR-TB) regimen. However, there is considerable concern regarding the subtherapeutic concentrations of the currently used doses and the development of...

NONMEM population pharmacokinetics and Monte Carlo dosing simulations of imipenem in critically ill patients with life-threatening severe infections during support with or without extracorporeal membrane oxygenation in an intensive care unit

Jaruratanasirikul S, Boonpeng A, Nawakitrangsan M, Samaeng M

Pharmacotherapy . 2021 Jun; 41(7):572-597. PMID: 34080708

Study Objectives: The objectives of this study were (i) to determine the population pharmacokinetic (PK) of imipenem in critically ill patients with life-threatening severe infections, (ii) to investigate the impact...

Validation of the Thai version of SARC-F, MSRA-7, and MSRA-5 questionnaires compared to AWGS 2019 and sarcopenia risks in older patients at a medical outpatient clinic

Akarapornkrailert P, Muangpaisan W, Boonpeng A, Daengdee D

Osteoporos Sarcopenia . 2021 Jan; 6(4):205-211. PMID: 33426310

Objectives: To validate the Thai Strength, Assistance with walking, Rise from a chair, Climb stairs and Falls (SARC-F), and 2 Mini Sarcopenia Risk Assessment (MSRA-5, and MSRA-7) questionnaires for sarcopenia...

Efficacy and Safety of Enteral Erythromycin Estolate in Combination With Intravenous Metoclopramide vs Intravenous Metoclopramide Monotherapy in Mechanically Ventilated Patients With Enteral Feeding Intolerance: A Randomized, Double-Blind,...

Charoensareerat T, Bhurayanontachai R, Sitaruno S, Navasakulpong A, Boonpeng A, Lerkiatbundit S, et al.

JPEN J Parenter Enteral Nutr . 2020 Sep; 45(6):1309-1318. PMID: 32895971

Background: In this pilot study, we aimed to determine the efficacy and safety of enteral erythromycin estolate in combination with intravenous metoclopramide compared to intravenous metoclopramide monotherapy in mechanically ventilated...

Optimal vancomycin dosing regimens for critically ill patients with acute kidney injury during continuous renal replacement therapy: A Monte Carlo simulation study

Charoensareerat T, Chaijamorn W, Boonpeng A, Srisawat N, Pummangura C, Pattharachayakul S

J Crit Care . 2019 Aug; 54:77-82. PMID: 31394493

Purpose: This study aims to determine the optimal vancomycin dosing in critically ill patients with acute kidney injury receiving continuous renal replacement therapy (CRRT) using Monte Carlo simulation. Methods: A...

10.

Doripenem dosing regimens in Asian critically ill patients with continuous renal replacement therapy

Chaijamorn W, Puchsaka P, Pattharachayakul S, Charoensareerat T, Srisawat N, Boonpeng A, et al.

J Crit Care . 2019 May; 52:233-236. PMID: 31108327

No abstract available.